Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

NCT06500299 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: HDM1002 100 mg QD
DRUG: HDM1002 200 mg QD 12weeks
DRUG: HDM1002 400 mg QD 12weeks
DRUG: Placebo

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.